Search

everythinglearnresearchcommunity

for

Search:↓

Melatonin and mitotane treatment led to hair re-growth in 62% of dogs with Alopecia X, but this was not always linked to normal hormone levels.

DNA variants can predict male pattern baldness, with higher risk scores increasing baldness likelihood.

Most dogs with alopecia had higher than normal levels of certain hormones, but hair loss might not always be linked to these hormone changes.

Steroidogenic isoenzymes may help improve treatments for common hair loss.

Early hair loss may indicate prostate issues.

Hair transplantation may work for some types of scarring alopecia, but results vary and more research is needed.

Hair loss risk is influenced by multiple genes.

Multimodal minoxidil microemulsion is more effective in treating hair loss than minoxidil alone.

Sex hormones affect hair and feather growth and may help manage alopecia and hormone-dependent cancers.

The exact cause of growth hormone-responsive alopecia in dogs is unclear.

Melatonin helped some Pomeranian dogs regrow hair, but it wasn't linked to estrogen receptors.

A new gel containing minoxidil can treat hair loss effectively, potentially reducing side effects and improving treatment.

Male pattern baldness involves hormone-related hair thinning, shorter hair, and inflammation.

Acitretin helped improve hand mobility and skin condition in a patient.

No strong proof that platelet-rich plasma effectively treats hair loss.

New oral treatment, finasteride, effectively and safely treats common hair loss.

The document concludes that androgenetic alopecia is common, has a genetic link, and can be diagnosed and treated with medications like finasteride and minoxidil.

Male androgenetic alopecia involves hair follicle miniaturization due to DHT, with potential treatments using inhibitors and blockers.

Plum-blossom needle therapy shows promise for treating hair loss but needs more research.

Trilostane treatment successfully restored hair growth in a dog with alopecia X.

Finasteride may effectively treat hair loss in Klinefelter Syndrome patients.

Frontal fibrosing alopecia in Brazil mostly affects postmenopausal women, often linked with hypothyroidism and eyebrow hair loss.

A girl with rickets and hair loss was found to have a rare condition where her body didn't respond to vitamin D treatment.

The conclusion is that primary scarring alopecia is a complex condition that requires early and accurate diagnosis for effective treatment.

EF and PXE not closely related.

Mutations in Plcd1 and Plcd3 together cause severe hair loss in mice.

Alopecia frontal fibrosante affects facial vellus hair and can be diagnosed with dermatoscopy.

Abnormal adrenal function is not the cause of alopecia in Pomeranians; it may be due to breed-specific hormones.

Melatonin-loaded microemulsion could be a promising treatment for hair loss.

The conclusion is that tritium-labeled testosterone metabolites can be made and are better converted into dihydrotestosterone in skin cells than in prostate tissue.